Xtant Medical (XTNT) 10-Q2023 Q1 Quarterly report

Filed: 4 May 23, 7:20am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: acquiree, approach, ascribed, assigned, assigning, assist, attrition, bank, banking, broader, certified, chief, clearing, CoFix, Coflex, concentration, conflict, constitute, constituted, construction, contemplated, contributory, custodial, data, decompression, delete, deposit, differentiated, difficult, diminish, disappoint, disclose, Discretionary, distressed, Drug, entity, Exhibit, expert, expose, exposed, fabric, failure, fall, farther, FDA, FDIC, Federal, federally, firm, fix, Food, forecast, forecasted, forma, furnished, GPO, Guarantee, guidance, hand, health, hire, hold, holding, hypothetical, illiquidity, inapplicable, incremental, industry, initiated, insolvent, instability, Institute, institution, Insurance, insured, invasive, January, lead, lending, life, lingering, low, lumbar, measure, measurement, met, minimally, moderate, motion, newly, numerical, obsolescence, occurrence, ongoing, opportunistic, outlook, Ownership, plant, policy, preliminary, premium, preserving, primary, pro, procurement, public, published, receivership, recency, recession, recognition, refine, registered, release, reliability, relief, Republic, response, responsibility, Russia, selecting, selection, Seller, sensitivity, separately, Signature, significantly, Silicon, size, slowdown, society, speculative, SPV, stability, stabilization, standalone, state, stream, subsidiary, Surgalign, SVP, Threshold, Ukraine, undue, urged, Valley, view, Worldwide

Removed: bad, cancelled, care, conducted, contemporaneously, continued, defer, depend, disrupting, diverted, effectively, emerge, ERP, execution, hardship, healthcare, indirect, issuable, lender, LIBOR, mature, mix, monitor, obsolete, onset, pandemic, patient, predicted, proper, recover, reduced, repaid, resurgence, role, scheduled, strain, subsequently, suffering, temporary, terminated, thereunder, transaction, treat, turn

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated XTNT transcripts

XTNT similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION of Chief Executive Officer PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2023 of Xtant Medical Holdings, Inc. (the “Company”), as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Sean E. Browne, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

	(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

May 4, 2023	/s/ Sean E. Browne
	Sean E. Browne
	President and Chief Executive Officer
	(Principal Executive Officer)